FDA Inspection 807222 — Biomat USA Inc

Biomat USA Inc — FEI 2077876

The FDA completed an inspection of Biomat USA Inc on October 30, 2012 in Calexico, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 30, 2012
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Calexico, CA (United States)

Citations

IDCFRDescription
1503021 CFR 606.60(b)Equipment calibration frequency
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs